The National Agency for Food and Drug Administration and Control (NAFDAC) has announced a sweeping regulatory action involving the immediate withdrawal, suspension, and cancellation of 101 pharmaceutical products across Nigeria.
Among the affected medicines are Penicillin G Sodium (Powder for Injection), Flagyl Suspension and Flagyl 400 mg Tablets, as well as Diclo-Neurobion Tablets, a combination of Diclofenac and B Vitamins.
These products were found to fall short of the agency’s approved standards for quality and safety.
Effective immediately, the listed products are banned from manufacture, importation, exportation, distribution, advertisement, sale, and use within the country.
NAFDAC emphasized that the decision was based on findings from post-market surveillance and regulatory inspections, aimed at ensuring that only safe, effective, and high-quality medicines remain available to the Nigerian public.
The agency clarified that the status of each product’s registration certificate varies depending on the specific circumstances.
READ ALSO: NAFDAC Raises Alarm Over Fake Postinor-2 Emergency Contraceptives Circulating in Nigeria
Some certificates have been voluntarily withdrawn by the market authorization holders, others suspended due to non-compliance with regulatory requirements, and some outright cancelled by NAFDAC.
In light of this development, NAFDAC has called on healthcare professionals, pharmacists, distributors, and the general public to immediately discontinue the use of the affected products.
The agency also urged citizens to report any adverse reactions or illegal trade activities related to these medicines, reinforcing its commitment to safeguarding public health.
Follow the Parallel Facts channel on WhatsApp: https://whatsapp.com/channel/0029VaCQSAoHgZWiDjR3Kn2E
